Profile Insights on Cellceutix Corp (OTCMKTS:CTIX)

Repost This

Las Vegas, NV -- (SBWIRE) -- 02/04/2014 -- Cellceutix Corp (OTCMKTS:CTIX) is a clinical stage biopharmaceutical company that is focused on discovery and development of small molecule drugs to treat drug-resistant cancers, psoriasis, autism and inflammatory diseases.

The flagship compound of Cellceutix Corp includes Kevetrin which is an anti-cancer compound that is in Phase I clinical trials for the treatment of cancer. The preclinical stage compounds of the company comprise KM 133 for the treatment of psoriasis, KM 277 for the treatment of arthritis and KM 278 for the treatment of arthritis/asthma and KM 391 for the treatment of autism. Its early stage research and development products include KM 362 for the treatment of MS/ALS/Parkinson’s disease, KM-3174 for the treatment of cancer and KM-732 for hypertensive emergency.

Cellceutix Corp also offers Brilacidin which is an antibiotic to treat various indications that include acute bacterial infections and skin structure infections that are caused by drug-sensitive or drug-resistant strains of Staphylococcus aureus bacteria, oral mucositis which is an oral rinse containing brilacidin and Delparantag which is a synthetic small-molecule. Moreover, the company provides compounds active against gram-negative bacteria, fungal infections, malaria, tuberculosis, biowarfare pathogens and PolyCide antimicrobial biomaterials.

To find out what OTCMAGIC projects for Cellceutix Corp for both short term and long term please click here: CTIX

OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in OTC Picks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers